This update is in follow-up to the FDA Communication about an Ongoing Safety Review of Stimulant Medications used in Children with Attention-Deficit/Hyperactivity Disorder (ADHD) Safety Announcement Additional Information for Patients Additional Information for Healthcare Professionals Data Summary Safety Announcement [11-01-2011] The U.S. Food and Drug Administration (FDA) is updating the public that a large, recently-completed study in [...]


Get updates to this site by email
LinkedIn
Twitter